Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ETHACRYNIC ACID USP, with a corresponding US DMF Number 32427.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 17, 2019, and payment made on April 08, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II